Skip to main content
. 2010 Oct 5;341:c5174. doi: 10.1136/bmj.c5174

Table 3.

 Characteristics of due care for reported and unreported cases of euthanasia*

All cases (n=137)‡ Cases reported to review committee (n=72) Unreported cases (n=64) P value
Weighted n Weighted percentage of cases (95% CI) Weighted n Weighted percentage of cases (95% CI) Weighted n Weighted percentage of cases (95% CI)
Type of request for euthanasia
Verbal request only 68 50.0 (40.1 to 60.5) 13 17.6 (9.1 to 31.5) 55 87.7 (76.6 to 93.9) <0.001†
Written request only 9 6.6 (2.3 to 18.0) 7 9.3 (2.4 to 29.9) 2 3.7 (0.9 to 14.5)
Verbal and written request 58 43.3 (33.5 to 53.1) 53 73.1 (56.8 to 84.9) 5 8.6 (3.9 to 18.0)
Decision discussed with others‡
Total 126 93.3 (80.2 to 97.8) 72 100 (100 to 100) 54 85.2 (63.0 to 95.1) 0.001†
 Other physician 106 77.0 (66.2 to 85.7) 71 97.5 (88.1 to 99.5) 35 54.6 (38.7 to 69.6) <0.001†
 Care giver specialised in palliative care 67 49.1 (39.2 to 59.6) 46 63.9 (49.6 to 76.2) 21 33.0 ( 21.3 to 47.2) <0.001†
 Nursing staff 72 53.5 (42.8 to 63.3) 39 54.3 (40.5 to 67.5) 33 51.9 (36.6 to 66.9) 0.864
 Relative 106 77.5 (66.0 to 85.8) 57 78.4 (63.6 to 88.4) 49 76.2 ( 57.4 to 88.4) 0.841
 Other persons 8 5.9 (2.9 to 11.9) 7 9.1 (4.2 to 18.7) 1 2.3 (0.3 to 15.0) 0.068
Drug used for euthanasia
Neuromuscular relaxant§ 15 11.2 (6.5 to 18.9) 15 22.1 (12.8 to 35.0) 0 <0.001†
Barbiturate¶ 21 15.7 (10.5 to 23.2) 18 26.5 (16.6 to 38.5) 3 4.8 (1.8 to 13.0)
Neuromuscular relaxant and barbiturate** 34 26.6 (17.7 to 36.8) 32 47.1 (34.0 to 61.9) 2 3.2 (1.0 to 10.3)
Opioids†† 60 45.5 (35.5 to 56.4) 3 4.4 (1.0 to 15.4) 57 90.5 (80.2 to 94.8)
Other drug 1 1.0 (0.2 to 4.1) 0 1 1.6 (0.5 to 8.3)
Person who administered the drug
Physician 96 72.2 (60.8 to 81.0) 69 97.9 (86.5 to 99.7) 27 43.0 (29.0 to 58.3) <0.001†
Nurse 26 19.3 (11.7 to 30.4) 0 26 41.3 (26.3 to 57.5)
Physician and nurse 9 7.4 (3.2 to 16.2) 1 2.1 (0.3 to 13.5) 8 13.4 (5.3 to 29.7)
Physician and other person 2 1.2 (0.3 to 4.8) 0 2 2.6 (0.6 to 10.0)

*All percentages are adjusted for stratification and for patient and mortality characteristics of all deaths in 2007, which makes the percentages representative for all deaths in Flanders in 2007.

P<0.05, using Fisher’s Exact (Monte Carlo).

‡One case was missing data on the variable “reporting of end of life decision.” Total numbers may not always amount to 137 because of rounding or missing values on variables. Percentages may not always amount to 100 because of rounding.

§ Neuromuscular relaxant alone or in conjunction with benzodiazepine, opioids, or other drug other than barbiturate.

Barbiturate alone or in conjunction with benzodiazepine, opioids, or other drug other than muscle relaxant.

**Neuromuscular relaxant and barbiturate, alone or in conjunction with benzodiazepine, opioids, or other drug.

††Opioids alone or in conjunction with benzodiazepine or other drug other than barbiturate or neuromuscular relaxant.